Skip to main content
Top
Published in: Diseases of the Colon & Rectum 5/2006

01-05-2006

Immunohistochemical Expression of p16, p53, and p63 in Colorectal Adenomas and Adenocarcinomas

Authors: Fabiana Pirani Carneiro, M.D., Leandra Náira Zambelli Ramalho, M.D., Ph.D., Sérgio Britto-Garcia, M.D., Ph.D., Alfredo Ribeiro-Silva, M.D., Ph.D., Sérgio Zucoloto, M.D., Ph.D.

Published in: Diseases of the Colon & Rectum | Issue 5/2006

Login to get access

Purpose

The aim of this study was to investigate the immunohistochemical expression of p16, p53, and p63 proteins according to some pathologic parameters related to colorectal adenomas and adenocarcinomas such as grade of dysplasia and histologic type.

Methods

Immunohistochemistry with the antibodies p16, p53, and p63 was performed in tubular, tubular-villous, and villous adenomas (n = 30) and in well, moderately, and poorly differentiated adenocarcinomas (n = 30). The p63-positive cases were submitted to double immunolabeling with the cytokeratin 5 (CK5).

Results

The p16 and p53 labelings were observed in some adenomas and adenocarcinomas but without any association with p63 expression, histologic type, or grade of differentiation of the neoplasm. P63 expression was found mainly in the villous adenomas and in the poorly differentiated adenocarcinomas. The poorly differentiated adenocarcinomas also exhibited coexpression of CK5 and p63.

Conclusions

Despite both p16 and p53 having been detected in colorectal neoplasms, they were not related to the different histologic variables nor to the expression of p63. However, p63 expression was closely associated with villous adenomas and poorly differentiated adenocarcinomas. Thus, p63 may represent a marker of poor differentiation in colorectal neoplasms. The coexpression of p63 and CK5 observed in this study could be related to divergent differentiation during the development of colorectal cancer, although further studies are warranted to refine the understanding of this process.
Literature
1.
go back to reference Parkin, DM, Bray, F, Ferlay, J, Pisani, P 2005Global cancer statistics, 2002CA Cancer J Clin5574108PubMedCrossRef Parkin, DM, Bray, F, Ferlay, J, Pisani, P 2005Global cancer statistics, 2002CA Cancer J Clin5574108PubMedCrossRef
2.
go back to reference Srivastava, S, Verma, M, Henson, DE 2001Biomarkers for early detection of colon cancerClin Cancer Res711181126PubMed Srivastava, S, Verma, M, Henson, DE 2001Biomarkers for early detection of colon cancerClin Cancer Res711181126PubMed
3.
go back to reference Rashid, A, Shen, L, Morris, JS, Issa, JP, Hamilton, SR 2001CpG island methylation in colorectal adenomasAm J Pathol15911291135PubMed Rashid, A, Shen, L, Morris, JS, Issa, JP, Hamilton, SR 2001CpG island methylation in colorectal adenomasAm J Pathol15911291135PubMed
4.
go back to reference Bond, JH 2000Polyp guideline: diagnosis, treatment and surveillance for patients with colorectal polypsAm J Gastroenterol9530533063CrossRefPubMed Bond, JH 2000Polyp guideline: diagnosis, treatment and surveillance for patients with colorectal polypsAm J Gastroenterol9530533063CrossRefPubMed
5.
go back to reference O'Brien, MJ, Winawer, SJ, Zauber, AG, et al. 1990The national polyp study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomasGastroenterology98371379PubMed O'Brien, MJ, Winawer, SJ, Zauber, AG,  et al. 1990The national polyp study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomasGastroenterology98371379PubMed
6.
go back to reference Gayet, J, Zhou, XP, Duval, A, Rolland, S, Hoang, JM, Cottu, P, Hamelin, R 2001Extensive characterization of genetic alterations in a series of human colorectal cancer cell linesOncogene3650255032CrossRef Gayet, J, Zhou, XP, Duval, A, Rolland, S, Hoang, JM, Cottu, P, Hamelin, R 2001Extensive characterization of genetic alterations in a series of human colorectal cancer cell linesOncogene3650255032CrossRef
7.
go back to reference Okamoto, A, Demetrick, DJ, Spillare, EA, et al. 1994Mutations and altered expression of p16INK4 in human cancerProc Natl Acad Sci USA231104511049 Okamoto, A, Demetrick, DJ, Spillare, EA,  et al. 1994Mutations and altered expression of p16INK4 in human cancerProc Natl Acad Sci USA231104511049
8.
go back to reference Burri, N, Shaw, P, Bouzourene, H, et al. 2001Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancerLab Invest2217229 Burri, N, Shaw, P, Bouzourene, H,  et al. 2001Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancerLab Invest2217229
9.
go back to reference Harms, K, Nozell, S, Chen, X 2004The common and distinct target genes of the p53 family transcription factorsCell Mol Life Sci61822842CrossRefPubMed Harms, K, Nozell, S, Chen, X 2004The common and distinct target genes of the p53 family transcription factorsCell Mol Life Sci61822842CrossRefPubMed
10.
go back to reference Moll, UM, Slade, N 2004P63 and p73: roles in development and tumor formationMol Cancer Res2371386PubMed Moll, UM, Slade, N 2004P63 and p73: roles in development and tumor formationMol Cancer Res2371386PubMed
11.
go back to reference Blandino, G, Dobbelstein, M 2004P73 and p63: why do we still need them?Cell Cycle3886894PubMed Blandino, G, Dobbelstein, M 2004P73 and p63: why do we still need them?Cell Cycle3886894PubMed
12.
go back to reference Levine, AJ, Levine, AJ, Momand, J, Finlay, CA 1991The p53 tumour suppressor geneNature351453456CrossRefPubMed Levine, AJ, Levine, AJ, Momand, J, Finlay, CA 1991The p53 tumour suppressor geneNature351453456CrossRefPubMed
13.
go back to reference Como, CJ, Urist, MJ, Babayan, I, et al. 2002P63 expression profiles in human normal and tumor tissuesClin Cancer Res2494501 Como, CJ, Urist, MJ, Babayan, I,  et al. 2002P63 expression profiles in human normal and tumor tissuesClin Cancer Res2494501
14.
go back to reference Reis-Filho, JS, Simpson, PT, Martins, A, Preto, A, Gartner, F, Schmitt, FC 2003Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarrayVirchows Arch2122132 Reis-Filho, JS, Simpson, PT, Martins, A, Preto, A, Gartner, F, Schmitt, FC 2003Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarrayVirchows Arch2122132
15.
go back to reference Nylander, K, Vojtesek, B, Nenutil, R, et al. 2002Differential expression of p63 isoforms in normal tissues and neoplastic cellsJ Pathol4417427CrossRef Nylander, K, Vojtesek, B, Nenutil, R,  et al. 2002Differential expression of p63 isoforms in normal tissues and neoplastic cellsJ Pathol4417427CrossRef
16.
go back to reference Muzio, L, Santarelli, A, Caltabiano, R, et al. 2005P63 overexpression associates with poor prognosis in head and neck squamous cell carcinomaHum Pathol2187194CrossRef Muzio, L, Santarelli, A, Caltabiano, R,  et al. 2005P63 overexpression associates with poor prognosis in head and neck squamous cell carcinomaHum Pathol2187194CrossRef
17.
go back to reference Ribeiro-Silva, A, Zambelli Ramalho, LN, Britto Garcia, S, Zucoloto, S 2003The relationship between p63 and p53 expression in normal and neoplastic breast tissueArch Pathol Lab Med3336340 Ribeiro-Silva, A, Zambelli Ramalho, LN, Britto Garcia, S, Zucoloto, S 2003The relationship between p63 and p53 expression in normal and neoplastic breast tissueArch Pathol Lab Med3336340
18.
go back to reference Foschini, MP, Gaiba, A, Cocchi, R, Pennesi, MG, Gatto, MR, Frezza, GP, Pession, A 2004Pattern of p63 expression in squamous cell carcinoma of the oral cavityVirchows Arch4332339CrossRef Foschini, MP, Gaiba, A, Cocchi, R, Pennesi, MG, Gatto, MR, Frezza, GP, Pession, A 2004Pattern of p63 expression in squamous cell carcinoma of the oral cavityVirchows Arch4332339CrossRef
19.
go back to reference Davis, LD, Zhang, W, Merseburger, A, et al. 2002P63 expression profile in normal and malignant prostate epithelial cellsAnticancer Res2238193825PubMed Davis, LD, Zhang, W, Merseburger, A,  et al. 2002P63 expression profile in normal and malignant prostate epithelial cellsAnticancer Res2238193825PubMed
20.
go back to reference Tsujita-Kyutoku, M, Kiuchi, K, Danbara, N, Yuri, T, Senzaki, H, Tsubura, A 2003P63 expression in normal human epidermis and epidermal appendages and their tumorsJ Cutan Pathol11117CrossRef Tsujita-Kyutoku, M, Kiuchi, K, Danbara, N, Yuri, T, Senzaki, H, Tsubura, A 2003P63 expression in normal human epidermis and epidermal appendages and their tumorsJ Cutan Pathol11117CrossRef
21.
go back to reference Wang, BY, Gil, J, Kaufman, D, Gan, L, Kohtz, DS, Burstein, DE 2002P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumorsHum Pathol9921926CrossRef Wang, BY, Gil, J, Kaufman, D, Gan, L, Kohtz, DS, Burstein, DE 2002P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumorsHum Pathol9921926CrossRef
22.
go back to reference Reis-Filho, JS, Torio, B, Albergaria, A, Schmitt, FC 2002P63 expression in normal skin and usual cutaneous carcinomasJ Cutan Pathol9517523CrossRef Reis-Filho, JS, Torio, B, Albergaria, A, Schmitt, FC 2002P63 expression in normal skin and usual cutaneous carcinomasJ Cutan Pathol9517523CrossRef
23.
go back to reference Glickman, JN, Yang, A, Shahsafaei, A, McKeon, F, Odze, RD 2001Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disordersHum Pathol1111571165CrossRef Glickman, JN, Yang, A, Shahsafaei, A, McKeon, F, Odze, RD 2001Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disordersHum Pathol1111571165CrossRef
24.
go back to reference Tannapfel, A, Schmelzer, S, Benicke, M, et al. 2001Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancerJ Pathol2163170CrossRef Tannapfel, A, Schmelzer, S, Benicke, M,  et al. 2001Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancerJ Pathol2163170CrossRef
25.
go back to reference Ito, Y, Takeda, T, Wakasa, K, Tsujimoto, M, Sakon, M, Matsuura, N 2001Expression of p73 and p63 proteins in pancreatic adenocarcinoma: p73 overexpression is inversely correlated with biological aggressivenessInt J Mol Med16771 Ito, Y, Takeda, T, Wakasa, K, Tsujimoto, M, Sakon, M, Matsuura, N 2001Expression of p73 and p63 proteins in pancreatic adenocarcinoma: p73 overexpression is inversely correlated with biological aggressivenessInt J Mol Med16771
26.
go back to reference O'Connell, JT, Mutter, GL, Cviko, A, et al. 2001Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63Gynecol Oncol13036CrossRef O'Connell, JT, Mutter, GL, Cviko, A,  et al. 2001Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63Gynecol Oncol13036CrossRef
27.
go back to reference Hall, PA, Woodman, AC, Campbell, SJ, Shepherd, NA 2001Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 proteinGut5618623CrossRef Hall, PA, Woodman, AC, Campbell, SJ, Shepherd, NA 2001Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 proteinGut5618623CrossRef
28.
go back to reference Parsa, R, Yang, A, McKeon, F, Green, H 1999Association of p63 with proliferative potential in normal and neoplastic human keratinocytesJ Invest Dermatol610991105CrossRef Parsa, R, Yang, A, McKeon, F, Green, H 1999Association of p63 with proliferative potential in normal and neoplastic human keratinocytesJ Invest Dermatol610991105CrossRef
29.
go back to reference Yang, A, Kaghad, M, Wang, Y, et al. 1998P63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activitiesMol Cell3305316CrossRef Yang, A, Kaghad, M, Wang, Y,  et al. 1998P63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activitiesMol Cell3305316CrossRef
30.
go back to reference Visca, P, Alo, PL, Nonno, F, et al. 1999Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosaClin Cancer Res1241114118 Visca, P, Alo, PL, Nonno, F,  et al. 1999Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosaClin Cancer Res1241114118
31.
go back to reference Yamaguchi, A, Kurosaka, Y, Fushida, S, Kanno, M, Yonemura, Y, Miwa, K, Miyazaki, I 1992Expression of p53 protein in colorectal cancer and its relationship to short-term prognosisCancer1227782784 Yamaguchi, A, Kurosaka, Y, Fushida, S, Kanno, M, Yonemura, Y, Miwa, K, Miyazaki, I 1992Expression of p53 protein in colorectal cancer and its relationship to short-term prognosisCancer1227782784
32.
go back to reference Campo, E, Calle-Martin, O, Miquel, R, et al. 1991Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomasCancer Res1644364442 Campo, E, Calle-Martin, O, Miquel, R,  et al. 1991Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomasCancer Res1644364442
33.
go back to reference Lanza, G,Jr, Maestri, I, Dubini, A, Gafa, R, Santini, A, Ferretti, S, Cavazzini, L 1996P53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survivalAm J Clin Pathol5604612 Lanza, G,Jr, Maestri, I, Dubini, A, Gafa, R, Santini, A, Ferretti, S, Cavazzini, L 1996P53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survivalAm J Clin Pathol5604612
34.
go back to reference Serrano, M, Hannon, GJ, Beach, D 1993A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4Nature366704707CrossRefPubMed Serrano, M, Hannon, GJ, Beach, D 1993A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4Nature366704707CrossRefPubMed
35.
go back to reference Tada, T, Watanabe, T, Kazama, S, Kanazawa, T, Hata, K, Komuro, Y, Nagawa, H 2003Reduced p16 expression correlates with lymphatic invasion in colorectal cancersHepatogastroenterology5417561760 Tada, T, Watanabe, T, Kazama, S, Kanazawa, T, Hata, K, Komuro, Y, Nagawa, H 2003Reduced p16 expression correlates with lymphatic invasion in colorectal cancersHepatogastroenterology5417561760
36.
go back to reference Dai, CY, Furth, EE, Mick, R, Koh, J, Takayama, T, Niitsu, Y, Enders, GH 2000P16 expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferationGastroenterology119929942CrossRefPubMed Dai, CY, Furth, EE, Mick, R, Koh, J, Takayama, T, Niitsu, Y, Enders, GH 2000P16 expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferationGastroenterology119929942CrossRefPubMed
Metadata
Title
Immunohistochemical Expression of p16, p53, and p63 in Colorectal Adenomas and Adenocarcinomas
Authors
Fabiana Pirani Carneiro, M.D.
Leandra Náira Zambelli Ramalho, M.D., Ph.D.
Sérgio Britto-Garcia, M.D., Ph.D.
Alfredo Ribeiro-Silva, M.D., Ph.D.
Sérgio Zucoloto, M.D., Ph.D.
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
Diseases of the Colon & Rectum / Issue 5/2006
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-006-0515-4

Other articles of this Issue 5/2006

Diseases of the Colon & Rectum 5/2006 Go to the issue

Selected Abstracts

Selected Abstracts